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Abstract
Metastases to the penis are extremely rare events. Most frequently, penile metastases come from the urogenital
system (bladder, prostate) or the rectum-sigmoid colon. Usually painful, penile lesions may be asymptomatic,
making diagnosis more challenging. Hence, we report the adding value of 18F-fludeoxyglucose–positron emission
tomography/computed tomography (18F-FDG PET/CT) in the detection of penile metastases originating from
urothelial carcinoma of the bladder. Arguably, penile metastases must be considered as an advanced disease
requiring essentially palliative care. Therefore, accurate staging of clinically localized muscle-invasive bladder cancer
is crucial to avoid useless curative intent radical surgery.
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Background
As bladder cancer management depends essentially on
the extent of the disease, accurate clinical staging is crucial
to select the most effective treatment [1]. Although penile
lesions are mostly revealed by a variety of symptoms,
some patients may be asymptomatic making diagnosis
more challenging. Hence, we report the adding value
of 18F-fludeoxyglucose–positron emission tomography/
computed tomography (18F-FDG PET/CT) as a valuable
method in the detection of penile metastases originating
from urothelial carcinoma of the bladder.
Case presentation
A 78-year-old man presented with macroscopic hematuria,
urinary frequency, and accidental leakage of urine. His past
medical history only included benign prostatic hyperplasia.
Initial assessment by fibroscopy showed a unique tumor
developed on the anterior wall of the bladder. The patient
underwent transurethral resection of the bladder tumor.
Pathological analysis reported high-grade muscle-invasive
urothelial carcinoma of the bladder (pT2 stage). The uro-
computed tomography (CT) scan did not show any
abnormality regarding the upper urinary tract. Meta-
static workup with thoracic and abdomino-pelvic CT
scan showed clinically localized bladder cancer. The
patient was then referred to our department to undergo
a curative intent surgery according to the multidiscip-
linary committee recommendations. Bilateral extended
pelvic lymphadenectomy with radical cystoprostatectomy
and ileal neobladder reconstruction were performed.
Definitive pathological analysis rendered pT2N0M0 high-
grade urothelial carcinoma (TNM 2009) with free surgical
borders, associated with prostatic adenocarcinoma Glea-
son score 7 (3 + 4), grade 4 involving 20 % of both pros-
tatic lobes. A total of 15 days after surgery, the patient
developed penile pain. Physical examination showed pain-
ful induration located on the right corpus cavernosum of
the penis. PET/CT imaging showed a high focal intense
uptake of 18F-FDG in the right corpus cavernosum of the
penis (Fig. 1). The report concluded that there was a high
suspicion of metastatic spread to the penis. Complemen-
tary penile magnetic resonance imaging (MRI) associated
with simultaneous fine needle biopsy were realized. Penile
MRI showed low to intermediate signal intensity as com-
pared with the surrounding corpus cavernosum on an
axial T2-weighted image (Fig. 2). Histopathological
examination from the right corpus cavernosum biopsy
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revealed carcinomatous tumor emboli from the urothe-
lial carcinoma of the bladder (Fig. 3). The patient was
referred to the medical oncologist for appropriate
treatment of the metastatic disease. Concomitant radio-
chemotherapy was decided according to the genitourinary
tumor board recommendations. This treatment included
local radiation associated with cisplatin-based regimen
chemotherapy. The patient received chemotherapy with
a combination of gemcitabine and carboplatin followed
by radiotherapy. Despite such intensive combined treat-
ment, metastatic cancer progression occurred and the
patient died.
Discussion
Penile metastases are extremely rare events. The most
common primary tumors concern the urogenital system
(i.e., bladder, prostate, and kidney) or the rectum-sigmoid
colon [2–4]. Indeed, physiopathology of metastases to the
penis is still unclear. Several mechanisms of dissemination
have been described. A usual way of spread seems to be
the retrograde venous dissemination from the pudendal
venous system into the dorsal venous system of the penis.
However, alternative ways have been evocated such as
retrograde lymphatic spread into penile lymphatic chan-
nels, iatrogenic implantation secondary to instrumenta-
tion, or direct extension from the primary tumor [2–4].
Interestingly, most cases of penile metastasis are meta-
chronous. The time interval between primary tumor and
penile metastasis ranges from 3 to 60 months. Indeed,
about two thirds of all penile metastases are diagnosed at
a meantime of 18 months after the detection of the pri-
mary tumor [5]. Moreover, penile metastases are usually
symptomatic. Most frequent are malignant priapism due
to the tumor infiltration of the corpus cavernosum
(>40 %), intense penile or perineal pain (≈10 %), penile
nodules or ulceration, generalized swelling of the penis,
and various urinary symptoms [2–4]. As previously re-
ported, penile metastases from urothelial carcinoma of the
bladder may be detected by either pelvic CT scan or MRI
[2–8]. Classically, the corpus cavernosum is the site of
involvement of metastatic penile carcinoma whereas the
glans penis and corpus spongiosum are rarely involved [6].
Even though MRI may able to distinguish metastatic lesion
from primary tumor of the penis, the presence of penile
lesion must be pathologically confirmed. Percutaneous
biopsies are also possible using penile block as anesthesia
[7]. However, as presented in our case report, penile metas-
tasis may be asymptomatic without any clinical sign of the
lesion at the time of staging. Indeed, abdomino-pelvic MRI
and/or CT scan do not systematically include the penis in
routine clinical practice. In this context, diagnosis may be
Fig. 1 PET image showing high 18F-fluorodeoxyglucose uptake in
the right corpus cavernosum
Fig. 2 Hyposignal intensity in the right corpus cavernosum on a
perineal axial T2-weighted slice
Fig. 3 Carcinomatous tumoral emboli from urothelial carcinoma of
the bladder occupying the erectile vascular tissue in the
corpus cavernosum
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more tricky and challenging. FDG/PET-CT analysis may
represent a valuable non-invasive technique which correctly
identifies such lesions providing an extensive staging in
a single session. Although 18F-FDG/PET-CT has been
shown to improve baseline staging in the nodal staging of
bladder cancer [1], controversy stills exists in relation to the
widespread use of PET/CT in clinical practice [9]. One of
the main reasons is its additional cost for a test with low
sensitivity [1].
Definitely, accurate staging of bladder cancer is crucial
to guide physicians in establishing the best therapeutic
strategy and to avoid useless curative intent treatment
option. Once penile metastasis has been diagnosed, the
prognosis is poor and death occurs rapidly [2]. The aver-
age survival in patients presenting with penile metastasis is
very short (i.e., 4 months from diagnosis), as it is highly
associated with advanced disease [3]. Conversely, only a few
cases of synchronous metastasis have been described. Over-
all, penile metastases must be considered as a non-curable
advanced multi-systemic disease requiring palliative therapy
such as local radiotherapy and systemic chemotherapy.
Partial or total penectomy may be discussed in order to
palliate painful symptoms. However, curative intent surgery
should be avoided. In our case report, metastasis became
evident 15 days after surgery, which is very prompt. Indeed,
the patient was asymptomatic and the abdomino-pelvic
CT scan did not show any abnormality at baseline sta-
ging. Hence, we hypothesize that penile metastasis was
already present at time of surgery. Arguably, this case
report strengthens the impact of 18F-FDG/PET-CT for
detecting asymptomatic penile metastasis originating from
muscle-invasive urothelial carcinoma of the bladder.
Conclusions
Despite its rarity, diagnosis of metastatic lesion to the
penis may be challenging particularly in asymptomatic
patients. Synchronous penile metastases should be con-
sidered as a multi-systemic disease with poor prognos-
tic. Thus, unncessary curative intent radical cystectomy
might be avoided. This report highlights the clinical
value of 18F-FDG/PET-CT to detect penile metasta-
ses originating from urothelial carcinoma. Therefore,
18F-FDG-PET/CT may help physicians to define the
best treatment strategy in patients with advanced blad-
der cancer.
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